Inactive Placebo
Sponsors
Medical University of South Carolina, Capnia, Inc., The Western Pennsylvania Hospital, University of Pennsylvania, Unity Health Toronto
Conditions
Acute Myocardial InfarctionAlcohol DependenceAlcohol Use DisorderAlcohol Use Disorder (AUD)Alcohol WithdrawalAlcohol Withdrawal DeliriumAlcohol Withdrawal SeizuresAlcoholism
Phase 2
The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines
CompletedNCT00690716
Start: 2008-08-31End: 2009-06-30Updated: 2012-08-15
A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers
CompletedNCT02371889
Start: 2014-12-18End: 2020-02-29Updated: 2022-01-20
Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD
RecruitingNCT06349083
Start: 2025-08-26End: 2029-05-31Target: 200Updated: 2025-12-19
Phase 3
Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone
CompletedNCT00183196
Start: 2003-01-31End: 2009-06-30Updated: 2018-06-07
Psilocybin for Major Depressive Disorder (MDD)
Active, not recruitingNCT06308653
Start: 2024-03-13End: 2026-12-30Target: 240Updated: 2025-12-15
Phase 4
Unknown Phase
Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome
TerminatedNCT03586089
Start: 2021-06-11End: 2023-07-17Updated: 2023-11-02
A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing Chemotherapy
RecruitingNCT06706752
Start: 2025-01-24End: 2025-12-31Target: 30Updated: 2025-05-15